Accendra Health, Inc. ACH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -171.56M | -302.14M | -1.08B | -1.10B | -1.34B |
| Total Depreciation and Amortization | 196.23M | 221.42M | 198.70M | 179.86M | 192.51M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -249.24M | -309.00M | 636.07M | 632.91M | 1.07B |
| Change in Net Operating Assets | 199.26M | 209.31M | 130.56M | 186.09M | -23.07M |
| Cash from Operations | -25.31M | -180.42M | -116.80M | -101.79M | -98.98M |
| Capital Expenditure | -141.53M | -144.49M | -154.53M | -158.68M | -195.67M |
| Sale of Property, Plant, and Equipment | 149.64M | 154.68M | 157.50M | 77.97M | 72.04M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 324.26M | 324.26M | 324.26M | 324.26M | -- |
| Other Investing Activities | -18.92M | -66.23M | -80.68M | -99.13M | -69.26M |
| Cash from Investing | 313.45M | 268.22M | 246.55M | 144.42M | -192.89M |
| Total Debt Issued | 2.41B | 3.07B | 2.41B | 2.91B | 3.26B |
| Total Debt Repaid | -2.64B | -3.21B | -2.25B | -2.71B | -3.02B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -3.52M | -3.52M | -8.68M | -10.18M | -6.66M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -68.57M | -18.77M | -2.44M | -5.24M | 31.18M |
| Cash from Financing | -307.79M | -157.29M | 146.38M | 188.08M | 262.48M |
| Foreign Exchange rate Adjustments | 89.00K | 54.00K | 1.31M | 1.90M | 458.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.56M | -69.44M | 277.44M | 232.61M | -28.92M |